MTHFR variants and supplements: what the evidence actually says

MTHFR might be the most over-Googled gene on the internet. Search it and you'll find claims that one variant explains your fatigue, anxiety, miscarriages, or heart disease — usually right before someone recommends an expensive "methylated" multivitamin. The reality is calmer and, frankly, more reassuring. These variants are extremely common, most people who carry one are perfectly healthy, and the evidence that carriers need special supplements is much thinner than the marketing suggests. Here's what the gene actually does, what the common variants change, and where the science is solid versus merely hopeful.

What MTHFR actually does

Your MTHFR gene carries the recipe for an enzyme — methylenetetrahydrofolate reductase — with one specific job in how your body handles folate (vitamin B9). According to MedlinePlus, the enzyme converts one form of folate (5,10-methylenetetrahydrofolate) into another form called 5-methyltetrahydrofolate, or 5-MTHF. That 5-MTHF is the main form of folate circulating in your blood, and it's needed to turn the amino acid homocysteine into methionine.

That last step matters for two reasons. First, methionine feeds "methylation," a background chemical process your cells use to build DNA and regulate genes. Second, it keeps homocysteine from piling up. The NIH Office of Dietary Supplements notes that blood homocysteine is a commonly used functional marker of folate status — when folate processing slows down, homocysteine tends to rise. Hold onto that word "marker"; it does a lot of work later.

The two common variants

Two single-letter changes in the MTHFR gene get almost all the attention: C677T and A1298C. Both slightly slow the enzyme, but they are not equal.

The enzyme-activity figures come from research summarized in the peer-reviewed literature on homocysteine-metabolism gene polymorphisms, and the population estimates from the NIH ODS folate fact sheet. Notice how ordinary these are. Cleveland Clinic estimates that up to half of all people carry at least one MTHFR variant. A "mutation" this widespread is really just normal human variation.

One important distinction: the common C677T and A1298C variants are completely different from the rare, severe mutations that cause a disease called homocystinuria. Homocystinuria involves dozens of different, function-destroying mutations and causes serious illness. The everyday variants people get from a 23andMe report do not.

Why most carriers are genuinely fine

This is the part the internet skips. Cleveland Clinic states plainly that MTHFR variants "don't cause health issues in most people who have them," most carriers have no symptoms, and there are no foods you need to avoid. Even among people with two copies of C677T — the highest-risk group — only around 2% end up with higher-than-normal homocysteine, and if your homocysteine is normal, your risk of complications doesn't appear to rise.

There's a practical reason for this. In the US and many other countries, grain products are fortified with folic acid, so most people take in enough folate to keep the pathway working even at reduced enzyme efficiency. A slower enzyme with plenty of raw material still gets the job done.

Homocysteine: the worry that didn't pan out

The whole MTHFR anxiety rests on a chain of logic: variant → higher homocysteine → heart attacks, strokes, and miscarriages. The first link is real but modest; the rest largely fell apart under testing.

Large randomized trials that lowered homocysteine using folic acid and other B vitamins mostly failed to reduce cardiovascular events. A meta-analysis of 16 trials with nearly 45,000 people found folic acid supplementation had essentially no effect on major cardiovascular events (relative risk 0.98), heart attacks, or overall mortality. And when the American College of Medical Genetics and Genomics reviewed the field, it concluded that meta-analyses have disproven the associations between elevated homocysteine and coronary heart disease, and between MTHFR variant status and venous blood clots. Homocysteine turned out to be more of a bystander flag than a cause you can fix your way to better outcomes.

Methylfolate vs. folic acid: honest version

Here's the pitch you've heard: because the MTHFR enzyme converts folate into 5-MTHF, people with variants should skip folic acid (which needs processing) and take pre-made 5-MTHF (methylfolate), which "bypasses" the faulty enzyme.

The mechanism is real. A 2022 review of 5-MTHF notes it is at least as bioavailable as folic acid, that supplementing it "bypasses" the potentially impaired MTHFR step, and that it produces less unmetabolized folic acid in the blood.

But mechanism is not the same as proven benefit. That same review leans heavily on bioavailability studies and observational data, and its authors concede that "more robust meta-analyses are needed" for the clinical outcomes people actually care about. There is no strong evidence that a healthy person with a common variant will feel better, live longer, or avoid disease by switching to methylfolate. For most people at normal doses, folic acid works fine. Methylfolate is a reasonable, well-tolerated choice — it just isn't the medical necessity it's marketed as.

One genuine cautionary note: the NIH ODS warns that high doses of folic acid can mask a vitamin B12 deficiency, correcting the anemia while nerve damage quietly progresses. That's an argument against megadosing folic acid, not against normal fortification. It's also why folate and B12 are best considered together — see our folic acid with vitamin B12 overview.

The B12 and B2 connection

MTHFR doesn't work alone. Vitamin B12 is the partner cofactor for the enzyme that actually uses 5-MTHF to convert homocysteine to methionine, which is why folate and B12 status rise and fall together.

Riboflavin (vitamin B2) is the more interesting and under-discussed player. Your body turns B2 into FAD, a cofactor the MTHFR enzyme physically needs to hold its shape — and the C677T variant makes the enzyme worse at gripping it. In a randomized trial in hypertensive adults, a modest 1.6 mg/day of riboflavin lowered blood pressure specifically in people with the TT genotype, and not in those with CC or CT. It's a striking example of a real gene-nutrient interaction — but note how narrow it is: a specific dose, a specific genotype, in people who already had high blood pressure. It's not a reason for everyone with a variant to start taking B2.

Who should actually get tested?

Mostly, no one — at least not for the variant itself. The ACMG practice guideline recommends against ordering MTHFR genotyping as part of a workup for blood clots or recurrent pregnancy loss, and against testing at-risk relatives, citing minimal clinical utility. Cleveland Clinic agrees that most people don't need the test because the result doesn't change their care. If a doctor is worried about your homocysteine, measuring homocysteine directly is far more useful than reading tea leaves from a genotype.

Pregnancy is where a dangerous myth shows up. Some people read about their variant and decide to skip folic acid. Don't. Public-health guidance recommends folic acid before and during early pregnancy to prevent neural tube defects, and folic acid is the form with the actual outcome evidence behind it. Having an MTHFR variant is not a reason to avoid it. If you'd prefer a methylated prenatal, that's a conversation to have with your OB or midwife — not a decision to make alone based on a raw-data report.

A quick medication note, too: drugs like methotrexate deliberately block folate, and long-term metformin can lower B12. If you take a medication that touches these pathways, ask your pharmacist before adding folate or B-vitamin supplements. You can also sanity-check specific combinations with our free interaction checker.

What to do if you have a variant

Keep it boring, because boring is what the evidence supports. Eat folate-rich foods (leafy greens, legumes, fortified grains) and aim for the roughly 400 mcg DFE daily that adults need, per the NIH ODS. A standard B-complex is plenty if your diet is thin; methylfolate is a fine choice but not a requirement. Don't megadose, don't panic, and don't drop proven prenatal folic acid over a gene result. If you're curious how your own variants map to folate, B12, and B2 — and want context rather than fear — our $29 DNA Supplement Report walks through MTHFR among other genes.

Bottom line

MTHFR variants are common, usually harmless, and wildly over-marketed. The C677T and A1298C changes modestly slow a folate enzyme, but most carriers have normal homocysteine and need no special treatment. Methylfolate is well-tolerated and bypasses the enzyme in theory, but strong evidence that carriers need it is lacking — folic acid remains the proven choice, especially in pregnancy. Routine genetic testing isn't recommended; if there's a real concern, checking homocysteine directly and talking to your doctor or pharmacist beats reacting to a genotype. A variant is a footnote in your biology, not a diagnosis.